| Abivax Sa | 329K | US$43.4M | 4.7% |
| Kodiak Sciences Inc | 1.06M | US$41.3M | 4.4% |
| Alumis Inc. | 871K | US$24.5M | 2.6% |
| Praxis Precision Medicines, Inc. | 72,842 | US$24.4M | 2.6% |
| Vaxcyte, Inc. | 389K | US$22.6M | 2.4% |
| Ani Pharmaceuticals, Inc. | 272K | US$22.5M | 2.4% |
| Celldex Therapeutics, Inc. | 479K | US$17.8M | 1.9% |
| Arcus Biosciences, Inc. | 505K | US$15.6M | 1.7% |
| Relmada Therapeutics, Inc. | 2.15M | US$14.9M | 1.6% |
| Capricor Therapeutics, Inc. | 604K | US$14.5M | 1.6% |
| Cogent Biosciences, Inc. | 370K | US$14.3M | 1.5% |
| Vera Therapeutics, Inc. | 310K | US$13.3M | 1.4% |
| Contineum Therapeutics, Inc. | 808K | US$13.2M | 1.4% |
| Tenax Therapeutics, Inc. | 788K | US$11.5M | 1.2% |
| C4 Therapeutics, Inc. | 2.43M | US$11.4M | 1.2% |
| Maze Therapeutics, Inc. | 379K | US$11.3M | 1.2% |
| Biohaven Ltd. | 748K | US$11.1M | 1.2% |
| Connect Biopharma Holdings Limited | 4.54M | US$10.8M | 1.2% |
| Alto Neuroscience, Inc. | 407K | US$10.7M | 1.2% |
| Jade Biosciences, Inc. | 427K | US$9.5M | 1.0% |
| Damora Therapeutics, Inc. | 336K | US$8.73M | 0.94% |
| Viridian Therapeutics, Inc. | 425K | US$7.81M | 0.84% |
| Pelthos Therapeutics Inc. | 257K | US$7.25M | 0.78% |
| Zura Bio Limited | 1.22M | US$7.19M | 0.77% |
| Tectonic Therapeutic, Inc. | 206K | US$7.08M | 0.76% |
| Spruce Biosciences, Inc. | 121K | US$6.55M | 0.71% |
| Hims & Hers Health, Inc. | 188K | US$6.53M | 0.70% |
| Enliven Therapeutics, Inc. | 127K | US$6.42M | 0.69% |
| Bright Minds Biosciences Inc. | 88,951 | US$6.24M | 0.67% |
| Ovid Therapeutics Inc. | 2.27M | US$6.11M | 0.66% |
| Ocugen, Inc. | 3.96M | US$6.06M | 0.65% |
| Alpha Cognition Inc. | 836K | US$6.04M | 0.65% |
| Harrow, Inc. | 136K | US$5.77M | 0.62% |
| Ultragenyx Pharmaceutical Inc. | 166K | US$5.53M | 0.60% |
| Q32 Bio Inc. | 430K | US$5.48M | 0.59% |
| Eupraxia Pharmaceuticals, Inc. | 810K | US$5.35M | 0.58% |
| Bioage Labs, Inc. | 200K | US$4.9M | 0.53% |
| Rezolute, Inc. | 935K | US$4.86M | 0.52% |
| Olema Pharmaceuticals, Inc. | 383K | US$4.79M | 0.52% |
| Monopar Therapeutics Inc. | 47,861 | US$4.43M | 0.48% |
| Bridgebio Pharma, Inc. | 57,417 | US$4.28M | 0.46% |
| Inventiva Sa | 1.13M | US$4.15M | 0.45% |
| Absci Corporation | 354K | US$4.1M | 0.44% |
| Alector, Inc. | 1.98M | US$3.99M | 0.43% |
| Climb Bio, Inc. | 300K | US$3.91M | 0.42% |
| Fulcrum Therapeutics, Inc. | 1.05M | US$3.84M | 0.41% |
| Cardiol Therapeutics Inc. Class A | 3.33M | US$3.52M | 0.38% |
| Cue Biopharma, Inc. | 104K | US$3.29M | 0.35% |
| Cumberland Pharmaceuticals Inc. | 503K | US$3.26M | 0.35% |
| Arrowhead Pharmaceuticals, Inc. | 38,278 | US$3.12M | 0.34% |
| Rein Therapeutics, Inc. | 2.95M | US$3.07M | 0.33% |
| Arvinas, Inc. | 358K | US$2.98M | 0.32% |
| Acumen Pharmaceuticals, Inc. | 1.05M | US$2.81M | 0.30% |
| Promis Neurosciences Inc. | 205K | US$2.7M | 0.29% |
| Annexon, Inc. | 430K | US$2.46M | 0.26% |
| Lexeo Therapeutics, Inc. | 513K | US$2.39M | 0.26% |
| Delcath Systems, Inc. | 186K | US$2.34M | 0.25% |
| Invivyd, Inc. | 2.66M | US$2.32M | 0.25% |
| Cabaletta Bio, Inc. | 700K | US$2.18M | 0.23% |
| Neumora Therapeutics, Inc. | 1.28M | US$2.17M | 0.23% |
| Amylyx Pharmaceuticals, Inc. | 118K | US$2.11M | 0.23% |
| Tarsus Pharmaceuticals, Inc. | 31,166 | US$1.96M | 0.21% |
| Journey Medical Corporation | 251K | US$1.78M | 0.19% |
| Dbv Technologies Sa | 525K | US$1.69M | 0.18% |
| Ibio, Inc. | 957K | US$1.67M | 0.18% |
| Avalo Therapeutics, Inc. | 90,183 | US$1.67M | 0.18% |
| Anteris Technologies Global Corp. | 167K | US$1.64M | 0.18% |
| Palisade Bio, Inc. | 750K | US$1.57M | 0.17% |
| Amanat Acquisition Corp | 150K | US$1.52M | 0.16% |
| Kalaris Therapeutics, Inc. | 360K | US$1.47M | 0.16% |
| Lipocine Inc. | 509K | US$1.3M | 0.14% |
| Immunome, Inc. | 60,000 | US$1.27M | 0.14% |
| Pliant Therapeutics, Inc. | 1M | US$1.14M | 0.12% |
| Immunic, Inc. | 67,464 | US$1.04M | 0.11% |
| Equillium, Inc. | 304K | US$971K | 0.10% |
| Neuronetics, Inc. | 701K | US$912K | 0.10% |
| Sensei Biotherapeutics, Inc. | 35,386 | US$885K | 0.10% |
| Fractyl Health, Inc. | 1.1M | US$874K | 0.09% |
| Cybin, Inc. | 132K | US$874K | 0.09% |
| First Tracks Biotherapeutics, Inc. | 42,775 | US$861K | 0.09% |
| Verastem, Inc. | 214K | US$817K | 0.09% |
| Pepgen Inc. | 447K | US$805K | 0.09% |
| Acadia Pharmaceuticals Inc. | 28,099 | US$711K | 0.08% |
| Cns Pharmaceuticals, Inc. | 136K | US$649K | 0.07% |
| Lyell Immunopharma, Inc. | 41,081 | US$577K | 0.06% |
| Passage Bio, Inc. | 99,517 | US$486K | 0.05% |
| Nextcure, Inc. | 288K | US$461K | 0.05% |
| Forte Biosciences, Inc. | 20,972 | US$446K | 0.05% |
| Solid Biosciences Inc. | 42,956 | US$429K | 0.05% |
| Traws Pharma, Inc. | 478K | US$403K | 0.04% |
| Lexicon Pharmaceuticals, Inc. | 165K | US$395K | 0.04% |
| Elicio Therapeutics, Inc. | 100K | US$391K | 0.04% |
| Inmed Pharmaceuticals Inc. | 245K | US$380K | 0.04% |
| Viking Therapeutics, Inc. | 9,717 | US$379K | 0.04% |
| Macrogenics, Inc. | 74,893 | US$346K | 0.04% |
| Hyperliquid Strategies Inc | 30,001 | US$236K | 0.03% |
| Cartesian Therapeutics, Inc. | 20,807 | US$217K | 0.02% |
| Neuphoria Therapeutics Inc. | 47,443 | US$207K | 0.02% |
| Voyager Therapeutics, Inc. | 53,063 | US$186K | 0.02% |
| Vyne Therapeutics Inc. | 265K | US$172K | 0.02% |